Table 1 Distribution of prognostic factors in different medication groupsa
Antidiabetic medication | Use of statins | |||||||
|---|---|---|---|---|---|---|---|---|
Metforminb | Other oral ADMb | Metformin and other oral ADMb | Insulin | No use of ADM | Yesb | No | Total | |
Number of patients | 77 | 58 | 100 | 82 | 104 | 186 | 235 | 421 |
Age at diagnosis, years | ||||||||
Median | 69 | 75 | 70 | 71 | 72 | 71 | 71 | 71 |
IQRc | 63─77 | 66─80 | 61─77 | 65─78 | 64─79 | 65─77 | 62─78 | 64─78 |
Age categories, years (%) | ||||||||
42─59 | 8 (10) | 6 (10) | 19 (19) | 9 (11) | 17 (16) | 18 (10) | 41 (17) | 59 (14) |
60─69 | 33 (43) | 13 (22) | 31 (31) | 28 (34) | 27 (26) | 66 (35) | 66 (28) | 132 (31) |
70─79 | 30 (39) | 24 (41) | 42 (42) | 29 (35) | 35 (34) | 74 (40) | 86 (37) | 160 (38) |
80─92 | 6 (8) | 15 (26) | 8 (8) | 16 (20) | 25 (24) | 28 (15) | 42 (18) | 70 (17) |
Duration of T2D, years (%) | ||||||||
Median | 3.1 | 5.0 | 6.2 | 10.8 | 7.0 | 6.3 | 5.7 | 6.2 |
IQRc | 2.0─5.5 | 3.1─8.3 | 4.1─8.9 | 6.8─15.0 | 2.0─10.1 | 3.1─10.0 | 3.1─10.0 | 3.1─10.1 |
0.5 ─ < 3 | 37 (48) | 15 (26) | 13 (13) | 4 (5) | 34 (33) | 45 (24) | 58 (25) | 103 (24) |
3 ─ < 6 | 24 (31) | 20 (34) | 30 (30) | 13 (16) | 13 (12) | 40 (22) | 60 (26) | 100 (24) |
6 ─ < 12 | 14 (18) | 19 (33) | 44 (44) | 30 (37) | 41 (39) | 71 (38) | 77 (33) | 148 (35) |
12 ─ < 34 | 2 (3) | 4 (7) | 13 (13) | 35 (43) | 16 (15) | 30 (16) | 40 (17) | 70 (17) |
Stage (%) | ||||||||
Local | 14 (18) | 6 (10) | 11 (11) | 11 (13) | 10 (10) | 24 (13) | 28 (12) | 52 (12) |
Advanced | 58 (75) | 45 (78) | 77 (77) | 64 (78) | 86 (83) | 142 (76) | 188 (80) | 330 (78) |
Unknown | 5 (6) | 7 (12) | 12 (12) | 7 (9) | 8 (8) | 20 (11) | 19 (8) | 39 (9) |